Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Why This Well-Timed Strategy is Forcing Them to Re-evaluate a Junior Oil Play in Texas

By Prodigy NewsG2 Energy Corp. is a Canadian, publicly-traded company (CSE:GTOO,OTCQB:GTGEF, FKN:UD9) focused on identifying and developing OVERLOOKED opportunities in the energy sector.The...
Research | July 14, 2022 |

Minimizing Mining Risk: The “Hybrid Opportunity Generator”

What sets certain companies apart from most others in the early-stage exploration space? A lot of the time it’s simply thinking outside of the box. In the case of Vancouver, BC-based junior exploration and development company Avrupa Minerals Ltd. (AVU)...
Dave Jackson | December 4, 2020 |

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...
Streetwise Reports | September 25, 2019 |

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection....
Streetwise Reports | October 4, 2019 |

Trillion Energy’s (CSE:TCF) Bayhanli-2 gas well enters production

Trillion Energy International Inc. ( CSE: TCF ) ( OTCQB: TRLEF ) (Frankfurt: Z62) announced flow test results for the Bayhanli-2 natural gas well at the SASB gas field, offshore Turkey. Eight intervals of gas pay with a true thickness of about 21 metres were perfor...
Maor Kagan | June 1, 2023 |

Insider Tips From a Capital Markets Guru on Trends

When it comes to capital markets, there are few more experienced to teach the do’s and don’ts of trading than Howard Katz – Managing Director of Mackie Research. In this insightful, intriguing and entertaining interview with Dave Jackson of...
Dave Jackson | August 27, 2020 |

3D printing is a manufacturing game-changer

Calling all carnivores: ever thought about getting a meat printer? Of hand-crafting delectable beef steaks at home from plant proteins, that have the same texture, appearance and flavor as real meat, only without the distasteful killing part? 3D-printed steaks and chicken ...
Richard (Rick) Mills | November 15, 2019 |

Three business reasons companies need to recycle e-waste

Author: Lane Simond . The most common narrative about recycling electronics is that it is better for the environment, but business owners have even more reasons to make sure their outdated technology gets into the hands of a reputable recycler. Three reasons to...
Research | December 18, 2024 |

Top Cannabis Stocks

If you’re looking to invest in cannabis stocks, there are a couple of different approaches you can take. It helps to look at many types of companies in different parts of the industry and see which looks the most promising for your portfolio. The cannabis s...
Stockhouse Editorial | November 29, 2021 |

Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research

Proteostasis Therapeutics' shares traded higher today after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-20...
Streetwise Reports | December 12, 2019 |
1 2 3 4 5 6 7 8 9 10 ...